Dr. Alrifai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Luther Ln
Ste 2200
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-318-2905
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Ascension Illinois/Saint Joseph (Chicago)Chief Residency, Internal Medicine, 2019 - 2020- Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 2016 - 2019
Damascus University Faculty of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Uncommon Presentation of Post-Transfusion Purpura in an Elderly Male: A Case Report and Unique Alloantibody Identification.Laura Owczarzak, Taha Alrifai, Shivi Jain, Irene Dehghan-Paz
The American Journal of Case Reports. 2024-07-09 - 3 citationsTransfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.Nicole K Yun, Taha Alrifai, Ira J Miller, Jamile M Shammo
Case Reports in Oncology. 2022-02-14 - 4 citationsPembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib.Nicole K. Yun, Taha Alrifai, Ira Miller, Melissa L. Larson
BMJ Case Reports. 2021-09-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
